CROSSROAD II: Activating Rural Clinics and Women With Disabilities to Improve Cancer Screening
NCT ID: NCT01773980
Last Updated: 2015-05-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1570 participants
OBSERVATIONAL
2013-08-31
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Support Program for Adoption of Cancer Screening Interventions at a Rural Community-Based Organization
NCT04208724
The Ohio State University (OSU) SCREEN Community Program
NCT06666192
Ohio Patient Navigator Research Program
NCT01569672
CBPR Strategies to Increase Colorectal Cancer Screening in Ohio Appalachia
NCT01904656
Rural Interventions for Screening Effectiveness
NCT02795104
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient and Clinic Intervention
The patient intervention consists of a single 90-minute interactive in-person session.
The Clinic intervention consists of an educational video, an interactive meeting with clinicians and clinic staff, and a facilitated follow-up meeting with clinic staff.
Clinic Intervention
The Clinic intervention consists of an educational video, an interactive meeting with clinicians and clinic staff, and a facilitated follow-up meeting with clinic staff.
Patient Intervention
The patient intervention consists of a single 90-minute interactive in-person session.
Patient Intervention Only
The patient intervention consists of a single 90-minute interactive in-person session.
Patient Intervention
The patient intervention consists of a single 90-minute interactive in-person session.
Clinic Intervention Only
The Clinic intervention consists of an educational video, an interactive meeting with clinicians and clinic staff, and a facilitated follow-up meeting with clinic staff.
Clinic Intervention
The Clinic intervention consists of an educational video, an interactive meeting with clinicians and clinic staff, and a facilitated follow-up meeting with clinic staff.
Neither Clinic nor Patient Intervention
Consists of no intervention
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Clinic Intervention
The Clinic intervention consists of an educational video, an interactive meeting with clinicians and clinic staff, and a facilitated follow-up meeting with clinic staff.
Patient Intervention
The patient intervention consists of a single 90-minute interactive in-person session.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 50-75 at time of screening
* No personal history of breast, cervical or colorectal cancer
* Not being up-to-date with at least one screening test for breast, cervical, and/or colorectal cancer
* Meets the study definition of disability per screening survey OR
* Be a woman who does not meet the definition of disability per screening survey, but has been matched to a participant who does (observation group).
Exclusion Criteria
* Personal history of breast, cervical, or colorectal cancer
* Coming into clinic for an urgent care issue
50 Years
75 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
OHSU Knight Cancer Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Buckley, MD
Role: PRINCIPAL_INVESTIGATOR
Oregon Health and Science University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
OHSU Knight Cancer Institute
Portland, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00009030
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.